Filter Results :

Your search for Virus returned 307 reports

Sort by


Zika Virus Vaccines by Company Profile, Deals Type, Funding, Clinical Trials Insight, Regulatory Landscape & Recent Development

03 Jan 2017  |  Published by:  DPI Research
It is predicted that Zika virus vaccines shot will available to the public by 2018.Zika virus is an emerging viral disease that is transmitted through the bite of an infected mosquito, primarily Aedes aegypti, the same vector that transmits chikungunya, dengue and yellow fever. Zika has a similar ep...

$ 900.00

Read More

Gardasil - human papillomavirus vaccine - Oncology drug report: 2006-2016 analysis, 2017-2021 expectations

03 Jan 2017  |  Published by:  Cancer Research Analytics
Gardasil: star cancer vaccine is a comprehensive drug report on the market leader of HPV vaccine segment (according to 2015 sales).In this report, Gardasil and Gardasil 9 are considered as a single product as Merck & Company reports the sales of both the vaccines collectively. Gardasil is the la...

$ 300.00

Read More

Human Papillomavirus (HPV) - Market Insights, Epidemiology and Market Forecast-2023

01 Jan 2017  |  Published by:  DelveInsight
Note*: This report requires 5-7 business days to complete.Human Papillomavirus (HPV) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Crohns disease for the seven major markets ie: United States, EU5 (France, German...

$ 4,950.00

Read More

Respiratory syncytial virus (RSV) - Epidemiology Forecast To 2023

01 Jan 2017  |  Published by:  DelveInsight
Respiratory syncytial virus (RSV) - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Respiratory syncytial virus (RSV) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Respir...

$ 2,750.00

Read More

Human Papillomavirus (HPV) - Epidemiology Forecast To 2023

01 Jan 2017  |  Published by:  DelveInsight
Human Papillomavirus (HPV) - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Human Papillomavirus (HPV) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Human Papillomavirus...

$ 2,750.00

Read More

Respiratory Syncytial Virus (RSV) Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Respiratory Syncytial Virus (RSV) Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Respiratory Syncyti...

$ 2,000.00

Read More

Vacina Rotavirus Humano G1P1[8] (Atenuada) -Drug Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Vacina Rotavirus Humano G1P1[8] (Atenuada)- Drug Insights, 2017 highlights the Vacina Rotavirus Humano G1P1[8] (Atenuada) marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsights report covers the Global Market Assessment of the Vacina Rotavirus H...

$ 1,000.00

Read More

Hepatitis C Virus (HCV) Protease Inhibitors -Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Hepatitis C Virus (HCV) Protease Inhibitors-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis C Virus (HCV) Protease Inhibitors. The DelveInsights Report covers the product profiles in various stages of development ...

$ 1,250.00

Read More

Respiratory syncytial virus (RSV) - Market Insights, Epidemiology and Market Forecast-2023

01 Jan 2017  |  Published by:  DelveInsight
Note*: This report requires 5-7 business days to complete.Respiratory syncytial virus (RSV) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Respiratory syncytial virus (RSV) for the seven major markets ie: United St...

$ 4,950.00

Read More

Adenovirus Infections-Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Adenovirus Infections-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Adenovirus Infections. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase...

$ 1,250.00

Read More

Cytomegalovirus (HHV-5) Infections-Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Cytomegalovirus (HHV-5) Infections-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Cytomegalovirus (HHV-5) Infections. The DelveInsightsReport covers the product profiles in various stages of development including Discovery...

$ 1,250.00

Read More

Enterovirus Infections-Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Enterovirus Infections-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Enterovirus Infections. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Pha...

$ 1,250.00

Read More

Human papillomavirus (HPV) Associated Cancer-Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Human papillomavirus (HPV) Associated Cancer-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Human papillomavirus (HPV) Associated Cancer. The DelveInsightsReport covers the product profiles in various stages of development...

$ 1,250.00

Read More

Human Papillomavirus Infections-Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Human Papillomavirus Infections-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Human Papillomavirus Infections. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-...

$ 1,250.00

Read More

Rhinovirus Infection-Pipeline Insights, 2017

01 Jan 2017  |  Published by:  DelveInsight
Rhinovirus Infection-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Rhinovirus Infection. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I...

$ 1,250.00

Read More
Total 307 records.